IL315164A - Arginase 2 vaccine - Google Patents
Arginase 2 vaccineInfo
- Publication number
- IL315164A IL315164A IL315164A IL31516424A IL315164A IL 315164 A IL315164 A IL 315164A IL 315164 A IL315164 A IL 315164A IL 31516424 A IL31516424 A IL 31516424A IL 315164 A IL315164 A IL 315164A
- Authority
- IL
- Israel
- Prior art keywords
- cells
- arg2
- polypeptide
- peptide
- hla
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/001154—Enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y305/00—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5)
- C12Y305/03—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5) in linear amidines (3.5.3)
- C12Y305/03001—Arginase (3.5.3.1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A61K2039/572—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 cytotoxic response
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/80—Vaccine for a specifically defined cancer
- A61K2039/852—Pancreas
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- General Engineering & Computer Science (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Endocrinology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2202547.2A GB202202547D0 (en) | 2022-02-24 | 2022-02-24 | Arginase 2 vaccine |
| GBGB2213372.2A GB202213372D0 (en) | 2022-09-13 | 2022-09-13 | Arginase 2 vaccine |
| PCT/EP2023/054568 WO2023161346A1 (en) | 2022-02-24 | 2023-02-23 | Arginase 2 vaccine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL315164A true IL315164A (en) | 2024-10-01 |
Family
ID=85415242
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL315164A IL315164A (en) | 2022-02-24 | 2023-02-23 | Arginase 2 vaccine |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250161422A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4482518A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2025508840A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240159833A (cg-RX-API-DMAC7.html) |
| CN (1) | CN119110729A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2023223567A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3250919A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL315164A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023161346A1 (cg-RX-API-DMAC7.html) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US58767A (en) | 1866-10-16 | John brougjbton | ||
| US5554372A (en) | 1986-09-22 | 1996-09-10 | Emory University | Methods and vaccines comprising surface-active copolymers |
| PL3522905T3 (pl) | 2016-10-07 | 2025-01-07 | Io Biotech Aps | Immunogenne peptydy arginazowe |
| AU2019201463A1 (en) * | 2018-03-09 | 2019-09-26 | Nantomics, Llc | Srm/mrm assays for profiling tumor tissue |
| GB201815549D0 (en) | 2018-09-24 | 2018-11-07 | Io Biotech Aps | Arginase1 polypeptides |
| US20210382068A1 (en) * | 2018-10-02 | 2021-12-09 | Dana-Farber Cancer Institute, Inc. | Hla single allele lines |
| GB201818576D0 (en) | 2018-11-14 | 2018-12-26 | Io Biotech Aps | Arginase 2 polypeptides |
-
2023
- 2023-02-23 US US18/841,338 patent/US20250161422A1/en active Pending
- 2023-02-23 IL IL315164A patent/IL315164A/en unknown
- 2023-02-23 CA CA3250919A patent/CA3250919A1/en active Pending
- 2023-02-23 JP JP2024550216A patent/JP2025508840A/ja active Pending
- 2023-02-23 CN CN202380023567.8A patent/CN119110729A/zh active Pending
- 2023-02-23 KR KR1020247031949A patent/KR20240159833A/ko active Pending
- 2023-02-23 AU AU2023223567A patent/AU2023223567A1/en active Pending
- 2023-02-23 WO PCT/EP2023/054568 patent/WO2023161346A1/en not_active Ceased
- 2023-02-23 EP EP23708178.1A patent/EP4482518A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2025508840A (ja) | 2025-04-10 |
| US20250161422A1 (en) | 2025-05-22 |
| CA3250919A1 (en) | 2023-08-31 |
| CN119110729A (zh) | 2024-12-10 |
| EP4482518A1 (en) | 2025-01-01 |
| AU2023223567A1 (en) | 2024-08-15 |
| KR20240159833A (ko) | 2024-11-06 |
| WO2023161346A1 (en) | 2023-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2020287902B2 (en) | TGF-beta vaccine | |
| US20250388674A1 (en) | Immunogenic arginase 2 polypeptides | |
| US20250205318A1 (en) | Arginase1 polypeptides | |
| US20250161422A1 (en) | Arginase 2 vaccine | |
| EP4611788A1 (en) | Tgf-beta-1 vaccine |